Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2009 |
| End Date: | November 2012 |
Pilot Study to Evaluate the Incremental Diagnostic Value of a Combined Molecular Breast Imaging / Breast Tomosynthesis Modality
The purpose of this pilot study is to investigate the potential clinical benefits of
combining two new diagnostic tools to provide co-registered anatomical and functional
information in the breast in patients with suspected breast cancer.
The purpose of this pilot study is to obtain preliminary data on a new way of imaging the
breast that combines the benefits of a 3-D anatomical technique (Digital Tomosynthesis) with
those of a functional imaging technique (Molecular Breast Imaging). Combining data from
these 2 modalities would provide co-registered functional and anatomical information on the
breast, in the same way that PET/CT does today in oncology. This should greatly facilitate
the evaluation and biopsy of lesions seen on MBI but occult on conventional mammography.
We found this trial at
1
site
Mayo Clinic College of Medicine Mayo Medical School enrolls a select class of 50 medical...
Click here to add this to my saved trials
